UK equities moved lower on Wednesday as investors assessed a mixed set of corporate earnings while shifting focus toward upcoming global central bank decisions, including the policy outlook from the Bank of England.
The blue-chip FTSE 100 index slipped 0.7% by 0950 GMT, marking its seventh decline in eight sessions.
Meanwhile, the mid-cap FTSE 250 index edged 0.1% lower, reflecting broader caution across the market.
Pharma and banking stocks weigh on benchmark
Healthcare stocks were among the biggest drags on the index.
AstraZeneca and GSK declined 1.4% and 2.1%, respectively, even after both pharmaceutical giants reported quarterly profits that exceeded expectations.
Despite the strong results, both companies maintained their full-year forecasts, which appeared to disappoint investors.
Banking stocks also faced pressure.
Lloyds Banking Group fell 1.4%, despite reporting a stronger-than-expected rise in first-quarter profit.
The muted reaction suggests that investors remain cautious about forward guidance and the broader economic outlook.
Geopolitical tensions keep investors cautious
Market sentiment remained fragile amid ongoing geopolitical uncertainty.
Investors are closely monitoring developments related to the Iran war, which continues to weigh on global risk appetite.
Efforts to resolve the conflict appear stalled.
US President Donald Trump is reportedly dissatisfied with the latest proposal from Tehran, insisting that nuclear issues be addressed from the outset.
The lack of progress has kept markets on edge, limiting any meaningful recovery in equities.
Focus shifts to central banks and tech earnings
Attention is now turning to a series of key global events that could influence market direction.
A Federal Reserve meeting later on Wednesday is expected to provide further clarity on the US interest rate outlook.
In addition, earnings from major US technology companies including Alphabet, Microsoft, Meta, and Amazon, are due shortly.
These results are likely to play a significant role in shaping broader market sentiment, particularly given the influence of megacap stocks on global indices, as reported by Reuters.
Bank of England decision in spotlight
Closer to home, the Bank of England is widely expected to keep interest rates unchanged in its upcoming policy decision on Thursday.
With geopolitical risks still elevated, policymakers are likely to adopt a cautious stance.
Despite recent declines, tentative optimism around a potential resolution to the US-Iran conflict has helped stabilise the FTSE 100.
The index is now on track to post a marginal gain for April, following what had been its worst monthly slump in six years due to the conflict, as mentioned in a Reuters report.
DCC surges on takeover interest
Among individual stocks, DCC stood out with a sharp rally.
Shares of the sales and marketing services provider surged 16% after the company confirmed it is reviewing a cash takeover proposal.
The bid comes from a consortium that includes US-based investment firms Energy Capital Partners and KKR.
The development boosted investor confidence, making DCC one of the top performers in the market during the session.
Overall, UK markets remain under pressure as investors balance corporate earnings signals with geopolitical developments and looming central bank decisions.
This post UK shares slip as earnings weigh ahead of central bank decisions appeared first on The ICD
Please note, this site provides content for entertainment purposes only and does not offer financial advice. Read more here
